These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 19174376)

  • 1. Accuracy of manual QRS duration assessment: its importance in patient selection for cardiac resynchronization and implantable cardioverter defibrillator therapy.
    Tomlinson DR; Bashir Y; Betts TR; Rajappan K
    Europace; 2009 May; 11(5):638-42. PubMed ID: 19174376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of changing oedematous states on the QRS duration: implications for cardiac resynchronization therapy and implantable cardioverter/defibrillator implantation.
    Madias JE
    Europace; 2005 Mar; 7(2):158-64. PubMed ID: 15763531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of computer-calculated and manual QRS duration assessments: Clinical implications to select candidates for cardiac resynchronization therapy.
    De Pooter J; El Haddad M; Stroobandt R; De Buyzere M; Timmermans F
    Int J Cardiol; 2017 Jun; 236():276-282. PubMed ID: 28169058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QRS duration in high-resolution methods and standard ECG in risk assessment after first and recurrent myocardial infarctions.
    Korhonen P; Husa T; Tierala I; Väänänen H; Mäkijärvi M; Katila T; Toivonen L
    Pacing Clin Electrophysiol; 2006 Aug; 29(8):830-6. PubMed ID: 16922998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precision and reproducibility of non-automatic measurement of the QRS complex in potential candidates for cardiac resynchronization therapy.
    Caro-Codón J; Rey JR; Díaz Cruz J; Martínez Marín LA; García de Veas Marquéz JM; Castrejón S; Martínez Cossiani M; Rodríguez Sotelo L; López-Sendón JL; Merino JL
    J Electrocardiol; 2019; 57():90-94. PubMed ID: 31574350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different Methods to Measure QRS Duration in CRT Patients: Impact on the Predictive Value of QRS Duration Parameters.
    De Pooter J; El Haddad M; Timmers L; Van Heuverswyn F; Jordaens L; Duytschaever M; Stroobandt R
    Ann Noninvasive Electrocardiol; 2016 May; 21(3):305-15. PubMed ID: 26391903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of prolonged QRS duration with death in a clinical trial of pacemaker therapy for sinus node dysfunction.
    Sweeney MO; Hellkamp AS; Lee KL; Lamas GA;
    Circulation; 2005 May; 111(19):2418-23. PubMed ID: 15867173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial attenuation of ECG voltage produces shortening of the corresponding QRS duration: clinical implications for patients with edema.
    Madias JE; Macfarlane PW
    Pacing Clin Electrophysiol; 2005 Oct; 28(10):1060-5. PubMed ID: 16221264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular lead placement in cardiac resynchronization therapy: where and how?
    Khan FZ; Virdee MS; Fynn SP; Dutka DP
    Europace; 2009 May; 11(5):554-61. PubMed ID: 19372115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices.
    Vatankulu MA; Goktekin O; Kaya MG; Ayhan S; Kucukdurmaz Z; Sutton R; Henein M
    Am J Cardiol; 2009 May; 103(9):1280-4. PubMed ID: 19406272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-ST elevation acute coronary syndrome: QRS duration and long-term prognosis.
    Rocha S; Torres M; Nabais S; Gaspar A; Rebelo A; Magalhães S; Salgado A; Azevedo P; Pereira MA; Correia A
    Rev Port Cardiol; 2009 Jun; 28(6):697-706. PubMed ID: 19697797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The variability of automated QRS duration measurement.
    Vancura V; Wichterle D; Ulc I; Šmíd J; Brabec M; Zárybnická M; Rokyta R
    Europace; 2017 Apr; 19(4):636-643. PubMed ID: 28431054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrocardiogram-based algorithm to predict the left ventricular lead position in recipients of cardiac resynchronization systems.
    Ploux S; Bordachar P; Deplagne A; Mokrani B; Reuter S; Laborderie J; Garrigue S; Delarche N; Jais P; Haissaguerre M; Clementy J
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S2-7. PubMed ID: 19250094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The optimized V-V interval determined by interventricular conduction times versus invasive measurement by LVdP/dtMAX.
    van Gelder BM; Meijer A; Bracke FA
    J Cardiovasc Electrophysiol; 2008 Sep; 19(9):939-44. PubMed ID: 18399968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-Analysis of the Usefulness of Change in QRS Width to Predict Response to Cardiac Resynchronization Therapy.
    Korantzopoulos P; Zhang Z; Li G; Fragakis N; Liu T
    Am J Cardiol; 2016 Nov; 118(9):1368-1373. PubMed ID: 27634027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision of automated QRS duration measurement in patients treated with cardiac resynchronization therapy.
    Lund-Andersen C; Petersen HH; Jøns C; Philbert BT; Tfelt-Hansen J; Skovgaard LT; Svendsen JH
    J Interv Card Electrophysiol; 2018 Jun; 52(1):103-110. PubMed ID: 29508111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.
    Roes SD; Borleffs CJ; van der Geest RJ; Westenberg JJ; Marsan NA; Kaandorp TA; Reiber JH; Zeppenfeld K; Lamb HJ; de Roos A; Schalij MJ; Bax JJ
    Circ Cardiovasc Imaging; 2009 May; 2(3):183-90. PubMed ID: 19808591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Where do derived precordial leads fail?
    Gregg RE; Zhou SH; Lindauer JM; Feild DQ; Helfenbein ED
    J Electrocardiol; 2008; 41(6):546-52. PubMed ID: 18817921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular conduction delays and relation to QRS configuration in patients with left ventricular dysfunction.
    Varma N
    Am J Cardiol; 2009 Jun; 103(11):1578-85. PubMed ID: 19463519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.